PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
The chloroquine resistance transporter (PfCRT) confers resistance to a wide range of quinoline and quinoline-like antimalarial drugs in Plasmodium falciparum, with local drug histories driving its evolution and, hence, the drug transport specificities. For example, the change in prescription practic...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-06-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1011436 |
_version_ | 1797736198080299008 |
---|---|
author | Guillermo M Gomez Giulia D'Arrigo Cecilia P Sanchez Fiona Berger Rebecca C Wade Michael Lanzer |
author_facet | Guillermo M Gomez Giulia D'Arrigo Cecilia P Sanchez Fiona Berger Rebecca C Wade Michael Lanzer |
author_sort | Guillermo M Gomez |
collection | DOAJ |
description | The chloroquine resistance transporter (PfCRT) confers resistance to a wide range of quinoline and quinoline-like antimalarial drugs in Plasmodium falciparum, with local drug histories driving its evolution and, hence, the drug transport specificities. For example, the change in prescription practice from chloroquine (CQ) to piperaquine (PPQ) in Southeast Asia has resulted in PfCRT variants that carry an additional mutation, leading to PPQ resistance and, concomitantly, to CQ re-sensitization. How this additional amino acid substitution guides such opposing changes in drug susceptibility is largely unclear. Here, we show by detailed kinetic analyses that both the CQ- and the PPQ-resistance conferring PfCRT variants can bind and transport both drugs. Surprisingly, the kinetic profiles revealed subtle yet significant differences, defining a threshold for in vivo CQ and PPQ resistance. Competition kinetics, together with docking and molecular dynamics simulations, show that the PfCRT variant from the Southeast Asian P. falciparum strain Dd2 can accept simultaneously both CQ and PPQ at distinct but allosterically interacting sites. Furthermore, combining existing mutations associated with PPQ resistance created a PfCRT isoform with unprecedented non-Michaelis-Menten kinetics and superior transport efficiency for both CQ and PPQ. Our study provides additional insights into the organization of the substrate binding cavity of PfCRT and, in addition, reveals perspectives for PfCRT variants with equal transport efficiencies for both PPQ and CQ. |
first_indexed | 2024-03-12T13:09:12Z |
format | Article |
id | doaj.art-4dfce052391d4bef93bf212ea18e6e8b |
institution | Directory Open Access Journal |
issn | 1553-7366 1553-7374 |
language | English |
last_indexed | 2024-03-12T13:09:12Z |
publishDate | 2023-06-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS Pathogens |
spelling | doaj.art-4dfce052391d4bef93bf212ea18e6e8b2023-08-28T05:30:42ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742023-06-01196e101143610.1371/journal.ppat.1011436PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.Guillermo M GomezGiulia D'ArrigoCecilia P SanchezFiona BergerRebecca C WadeMichael LanzerThe chloroquine resistance transporter (PfCRT) confers resistance to a wide range of quinoline and quinoline-like antimalarial drugs in Plasmodium falciparum, with local drug histories driving its evolution and, hence, the drug transport specificities. For example, the change in prescription practice from chloroquine (CQ) to piperaquine (PPQ) in Southeast Asia has resulted in PfCRT variants that carry an additional mutation, leading to PPQ resistance and, concomitantly, to CQ re-sensitization. How this additional amino acid substitution guides such opposing changes in drug susceptibility is largely unclear. Here, we show by detailed kinetic analyses that both the CQ- and the PPQ-resistance conferring PfCRT variants can bind and transport both drugs. Surprisingly, the kinetic profiles revealed subtle yet significant differences, defining a threshold for in vivo CQ and PPQ resistance. Competition kinetics, together with docking and molecular dynamics simulations, show that the PfCRT variant from the Southeast Asian P. falciparum strain Dd2 can accept simultaneously both CQ and PPQ at distinct but allosterically interacting sites. Furthermore, combining existing mutations associated with PPQ resistance created a PfCRT isoform with unprecedented non-Michaelis-Menten kinetics and superior transport efficiency for both CQ and PPQ. Our study provides additional insights into the organization of the substrate binding cavity of PfCRT and, in addition, reveals perspectives for PfCRT variants with equal transport efficiencies for both PPQ and CQ.https://doi.org/10.1371/journal.ppat.1011436 |
spellingShingle | Guillermo M Gomez Giulia D'Arrigo Cecilia P Sanchez Fiona Berger Rebecca C Wade Michael Lanzer PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport. PLoS Pathogens |
title | PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport. |
title_full | PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport. |
title_fullStr | PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport. |
title_full_unstemmed | PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport. |
title_short | PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport. |
title_sort | pfcrt mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport |
url | https://doi.org/10.1371/journal.ppat.1011436 |
work_keys_str_mv | AT guillermomgomez pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport AT giuliadarrigo pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport AT ceciliapsanchez pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport AT fionaberger pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport AT rebeccacwade pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport AT michaellanzer pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport |